Celanese Corp (CE) Form 10-Q — Nov 3, 2026
Celanese posted Q3 2026 net sales of $2,556 million, up 6% year over year, and swung to net earnings of $74 million ($0.67 per share) from a $1,357 million loss in Q3 2025 that had been driven by roughly $1.5 billion of non-cash goodwill and trade-name impairments. The company continued its deleveraging push: it completed the $493 million sale of its Micromax business to Element Solutions in February (booking a $50 million gain) and signed an agreement to sell 19% of its Nutrinova food-ingredients JV to Mitsui for about $152 million, expected to close in Q4 2026. Total debt fell to $11.5 billion from $12.6 billion at year-end 2025.
Key figures
- Eps
- 0.67
- Revenue
- 2556
- Net Income
- 74
- Total Debt
- 11545
- Revenue Yoy
- 6% (Q3 2026 vs Q3 2025)
- Cash Position
- 1362
- Micromax gain musd
- 50
- Nine month revenue
- 7645
- Shares outstanding
- 109752752
- Nine month net income
- 243
- Q3 operating margin pct
- 7.7
- Revolver available musd
- 1750
- Micromax sale price musd
- 493
- Effective tax rate q3 pct
- 15
- Lanaken remaining costs musd
- 15
- Quarterly dividend per share
- 0.03
- Lanaken closure costs to date musd
- 94
- Nutrinova stake sale proceeds musd
- 152
- Goodwill engineered materials fair value headroom pct
- 8
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.